Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience.

被引:0
|
作者
Lee, Jongchan
Lee, Jong-Chan
Kim, Hyoung Woo
Kim, Jaihwan
Hwang, Jin-Hyeok
机构
[1] Seoul Natl Univ, Bundang Hosp, Seongnam Si, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam Si, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea
关键词
D O I
10.1200/JCO.2017.35.4_suppl.480
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
480
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Irreversible electroporation for Stage III locally advanced pancreatic cancer: Single-center experience
    Spiliotis, John
    Kopanakis, Nikolaos
    Terras, Alexis
    Efstathiou, Elias
    JOURNAL OF BUON, 2018, 23 (04): : 1203 - 1204
  • [42] FOLFIRINOX FOR LOCALLY ADVANCED OR METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (PDA); CLINICAL OUTCOMES AND PROGNOSTIC FACTORS, THE ROYAL MARSDEN (RM) EXPERIENCE
    Yu, Moorcraft Sing
    Khurum, Khan
    Clare, Peckitt
    David, Watkins
    Sheela, Rao
    David, Cunningham
    Ian, Chau
    ANNALS OF ONCOLOGY, 2014, 25 : 78 - 78
  • [43] Institution experience of FOLFIRINOX chemotherapy in advanced pancreatic cancer
    Haddadin, Y.
    Herbertson, R.
    Webb, A.
    Selvadurai, E.
    Robinson, A.
    Cornah, I.
    ANNALS OF ONCOLOGY, 2016, 27 : 54 - 54
  • [44] Did multiagent chemotherapy improve clinical outcomes of advanced pancreatic cancer? A single center experience of 408 cases
    Nakai, Yousuke
    Isayama, Hiroyuki
    Ishigaki, Kazunaga
    Takahara, Naminatsu
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [45] FOLFIRINOX for advanced pancreatic cancer: The Princess Margaret experience
    Chllamma, Muralidharan
    Cook, Natalie
    Giby, Kazim
    Dodd, Anna
    Wang, Lisa
    Dhani, Neesha C.
    Hedley, David W.
    Moore, Malcolm J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [46] Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
    Boone, Brian A.
    Steve, Jennifer
    Krasinskas, Alyssa M.
    Zureikat, Amer H.
    Lembersky, Barry C.
    Gibson, Michael K.
    Stoller, Ronald G.
    Zeh, Herbert J.
    Bahary, Nathan
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (04) : 236 - 241
  • [47] Retrospective single center review of toxicity and efficacy of a modified FOLFIRINOX regimen in patients with locally advanced and metastatic pancreatic cancer.
    Pulluri, Bhargavi
    Skelly, Joan
    Barry, Maura Meredith
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [48] FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
    Krishna S. Gunturu
    Xiaopan Yao
    Xiangyu Cong
    Jaykumar R. Thumar
    Howard S. Hochster
    Stacey M. Stein
    Jill Lacy
    Medical Oncology, 2013, 30
  • [49] FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
    Gunturu, Krishna S.
    Yao, Xiaopan
    Cong, Xiangyu
    Thumar, Jaykumar R.
    Hochster, Howard S.
    Stein, Stacey M.
    Lacy, Jill
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [50] Anticoagulation outcomes in patients with venous thromboembolism following Whipple surgery for pancreatic cancer: Single center experience.
    Balanchivadze, Nino
    Purtell, James P.
    Kuriakose, Philip
    Clark, Julie
    Springer, Kylie
    Divine, George
    Kwon, David S.
    Dobrosotskaya, Irina Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)